CARsgen Therapeutics saw the highest growth of 1.49% in patent filings in June and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of CARsgen Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
CARsgen Therapeutics has been focused on protecting inventions in China(CN) with three publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 40% filings and 50% grants. The China(CN), European Patent Office(EPO), United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where CARsgen Therapeutics is filings its patents. Among the top granted patent authorities, CARsgen Therapeutics has 50% of its grants in China(CN) and 50% in Israel(IL).
Roche and Johnson & Johnson could be the strongest competitors for CARsgen Therapeutics
Patents related to cell & gene therapy and immuno-oncology lead CARsgen Therapeutics's portfolio
CARsgen Therapeutics has the highest number of patents in cell & gene therapy followed by, immuno-oncology and rare diseases. For cell & gene therapy, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Leukemia related patents lead CARsgen Therapeutics portfolio followed by hematological tumor, and lymphoma
CARsgen Therapeutics has highest number of patents in leukemia followed by hematological tumor, lymphoma, melanoma, and wilms' tumor (nephroblastoma).
For comprehensive analysis of CARsgen Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
